Chondrosarcoma Clinical Trials in Georgia

Cancer Type = Chondrosarcoma

Cancer Type = Chondrosarcoma

There are currently 1 active Chondrosarcoma clinical trials in Georgia.
1.
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Cancer Type
Bone and Soft Tissue (including Sarcoma), Chondrosarcoma
NCI ID
NCT02601937
Protocol IDs
EZH-102
NCI-2015-02224
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.